Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-steroidal Anti-inflammatory Drugs (Meloxicam) to Mobilize Hematopoietic Stem Cells: A Phase II Randomized Trial

NCT02003625 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02003625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02003625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-steroidal Anti-inflammatory Drugs (Meloxicam) to Mobilize Hematopoietic Stem Cells: A Phase II Randomized Trial
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2013
Completion date
April 30, 2019
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic stem cells, hodgkin's lymphoma, multiple myeloma, non-hodgkin's lymphoma